The Scientist

» FDA and genetics & genomics

Most Recent

image: TS Picks: September 8, 2015

TS Picks: September 8, 2015

By | September 8, 2015

Pharma edition

0 Comments

image: Unexpectedly Wild

Unexpectedly Wild

By | September 1, 2015

Genomic analysis reveals pigs interbred with wild boars during domestication.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | September 1, 2015

Brain Storms, Orphan, Maize for the Gods, and Paranoid.

0 Comments

image: The Sounds of Silence

The Sounds of Silence

By | September 1, 2015

Science-based tinnitus therapeutics are finally coming into their own.

3 Comments

image: Opinion: Engineering the Epigenome

Opinion: Engineering the Epigenome

By , , and | August 26, 2015

The use of targetable chromatin modifiers has ushered in a new era of functional epigenomics.

1 Comment

image: Alphabet Announces Life Sciences

Alphabet Announces Life Sciences

By | August 24, 2015

Google’s parent company is launching a research-and-development project as a standalone firm.

0 Comments

image: Valeant Scoops Sprout for $1 Billion

Valeant Scoops Sprout for $1 Billion

By | August 24, 2015

The Canadian pharmaceutical firm is buying the American drugmaker behind the newly approved “female Viagra.”

0 Comments

image: Illumina, Investors Launch Consumer Genetics Firm

Illumina, Investors Launch Consumer Genetics Firm

By | August 19, 2015

With $100 million in initial funding, Helix aims to make personal genomics accessible.

1 Comment

image: “Female Viagra” Approved

“Female Viagra” Approved

By | August 19, 2015

The US Food and Drug Administration OKs the first drug for female sexual dysfunction.

0 Comments

image: Report: Impact of Biomedical Research Slipping

Report: Impact of Biomedical Research Slipping

By | August 18, 2015

Despite dramatic increases in publications, the last 50 years have seen relatively little return on investment for US public health, a study suggests.

15 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. March for Science: Dispatches from Washington, DC
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS